Cargando…

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Taleja, Hitesh, Nair, Vipin Venugopal, Yadav, Sunanda, Venkatnarayanan, Raghavendra, Roy, Nilanjan, Rao, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678264/
http://dx.doi.org/10.1159/000518931
_version_ 1784616294880903168
author Taleja, Hitesh
Nair, Vipin Venugopal
Yadav, Sunanda
Venkatnarayanan, Raghavendra
Roy, Nilanjan
Rao, Pankaj
author_facet Taleja, Hitesh
Nair, Vipin Venugopal
Yadav, Sunanda
Venkatnarayanan, Raghavendra
Roy, Nilanjan
Rao, Pankaj
author_sort Taleja, Hitesh
collection PubMed
description BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and may manifest like hematomas in atypical locations. These bleeding manifestations may be spontaneous or can be induced by even minor trauma. CASES: It is a single-center retrospective analysis. Four patients with a confirmed diagnosis of COVID-19 depicting increased risk of bleeding manifestations were included. Patients in our study were managed as per guidelines recommended by the Ministry of Health and Family Welfare Directorate General of Health Services, Government of India. RESULTS: All patients were male. The mean age was 56 ± 18.64 years. One patient was managed conservatively with discontinuation of anticoagulants, volume resuscitation, and transfusion of blood products. Drainage with incision was done for 2 patients. One was managed with pigtail drainage. CONCLUSION: The effect of anticoagulants given in therapy and their varied presentations are discussed in this article. The article concludes that we need vigilant observation to identify this complication in the early period, resulting in successful management.
format Online
Article
Text
id pubmed-8678264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-86782642021-12-17 Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin Taleja, Hitesh Nair, Vipin Venugopal Yadav, Sunanda Venkatnarayanan, Raghavendra Roy, Nilanjan Rao, Pankaj Dubai Medical Journal Complementary Medicine − Case Report BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and may manifest like hematomas in atypical locations. These bleeding manifestations may be spontaneous or can be induced by even minor trauma. CASES: It is a single-center retrospective analysis. Four patients with a confirmed diagnosis of COVID-19 depicting increased risk of bleeding manifestations were included. Patients in our study were managed as per guidelines recommended by the Ministry of Health and Family Welfare Directorate General of Health Services, Government of India. RESULTS: All patients were male. The mean age was 56 ± 18.64 years. One patient was managed conservatively with discontinuation of anticoagulants, volume resuscitation, and transfusion of blood products. Drainage with incision was done for 2 patients. One was managed with pigtail drainage. CONCLUSION: The effect of anticoagulants given in therapy and their varied presentations are discussed in this article. The article concludes that we need vigilant observation to identify this complication in the early period, resulting in successful management. S. Karger AG 2021-09-20 /pmc/articles/PMC8678264/ http://dx.doi.org/10.1159/000518931 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Complementary Medicine − Case Report
Taleja, Hitesh
Nair, Vipin Venugopal
Yadav, Sunanda
Venkatnarayanan, Raghavendra
Roy, Nilanjan
Rao, Pankaj
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title_full Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title_fullStr Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title_full_unstemmed Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title_short Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
title_sort spontaneous hematomas in covid-19 patients on low-molecular-weight heparin
topic Complementary Medicine − Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678264/
http://dx.doi.org/10.1159/000518931
work_keys_str_mv AT talejahitesh spontaneoushematomasincovid19patientsonlowmolecularweightheparin
AT nairvipinvenugopal spontaneoushematomasincovid19patientsonlowmolecularweightheparin
AT yadavsunanda spontaneoushematomasincovid19patientsonlowmolecularweightheparin
AT venkatnarayananraghavendra spontaneoushematomasincovid19patientsonlowmolecularweightheparin
AT roynilanjan spontaneoushematomasincovid19patientsonlowmolecularweightheparin
AT raopankaj spontaneoushematomasincovid19patientsonlowmolecularweightheparin